Physician profile
Wilson P Smith
NPI 1982675625
$17,179.36
in general payments reported to CMS, 2019-2025
48 companies · $3,067 in 2025
The $3,067 reported for 2025 was more than what 90% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,183 · 2020: $1,441 · 2021: $2,241 · 2022: $2,524 · 2023: $2,749 · 2024: $2,974 · 2025: $3,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,759 · Education: $30.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,759.04 |
| Education | $30.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,268.88 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $2,169.40 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,927.62 | 2019-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Grifols USA, LLC | $1,087.55 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Insmed, INC. | $991.07 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $916.38 | 2019-2025 | Opsumit, Uptravi |
| Electromed, INC. | $852.21 | 2019-2025 | Smartvest |
| Gilead Sciences, INC. | $738.65 | 2021-2024 | Veklury |
| Harmony Biosciences LLC | $665.38 | 2020-2025 | Wakix |
| Regeneron Healthcare Solutions, INC. | $571.57 | 2021-2025 | Dupixent |
| Axsome Therapeutics, INC. | $537.27 | 2023-2025 | Sunosi |
| Genzyme Corporation | $523.42 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $520.90 | 2023-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $428.58 | 2021-2023 | Xywav |
| Verona Pharma, INC. | $320.90 | 2025 | Ohtuvayre |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $295.63 | 2019-2023 | Xolair |
| Mylan Specialty L.P. | $255.10 | 2019-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $206.46 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.10 | 2020-2025 | Glassia |
| Sunovion Pharmaceuticals INC. | $141.85 | 2019-2021 | |
| Genentech, INC. | $128.57 | 2021 | |
| Ani Pharmaceuticals, INC. | $122.93 | 2023-2025 | Purified Cortrophin Gel |
| Philips North America LLC | $118.38 | 2019-2025 | Vest Therapy Und |
| Teva Pharmaceuticals USA, INC. | $114.21 | 2019-2022 | |
| Viatris Specialty LLC | $104.56 | 2025 | Yupelri |
| Advanced Respiratory, INC | $94.34 | 2020-2021 | |
| Inspire Medical Systems, INC. | $80.13 | 2023-2025 | Inspire |
| Fisher & Paykel Healthcare INC | $78.36 | 2019 | |
| Portola Pharmaceuticals, LLC | $76.58 | 2019-2020 | |
| Circassia INC. | $65.89 | 2019-2020 | |
| Inogen, INC. | $64.70 | 2021-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| United Therapeutics Corporation | $64.38 | 2020-2025 | Tyvaso |
| Merck Sharp & Dohme LLC | $57.43 | 2025 | Winrevair, Keytruda |
| Resmed Corp | $56.72 | 2019-2023 | |
| Baxter Healthcare | $53.50 | 2023 | Hillrom - Life 2000 Ventilation System |
| Melinta Therapeutics, LLC | $39.60 | 2021 | |
| Nabriva Therapeutics, Plc | $39.58 | 2021 | |
| Vifor Pharma, INC. | $37.27 | 2025 | Zemaira |
| La Jolla Pharmaceutical Company | $23.66 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.96 | 2019 | |
| Pulmonx Corporation | $21.90 | 2023 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Lilly USA, LLC | $21.74 | 2025 | Zepbound |
| Itamar Medical INC | $21.34 | 2025 | Watchpatone |
| Gc Biopharma USA, INC. | $18.64 | 2025 | Alyglo |
| Vapotherm INC | $15.65 | 2022 | |
| Veran Medical Technologies, INC. | $14.15 | 2020 | |
| Pfizer INC. | $13.69 | 2022 | |
| Mallinckrodt Enterprises LLC | $13.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wilson Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.